INS and type 2 diabetes mellitus: Clinical trials ONWARDS 2 and 5 investigated the general patient satisfaction with insulin icodec treatment, compared with degludec or degludec/glargine, respectively, in patients with T2DM, using some validated tools that measured treatment satisfaction and patient compliance [36,39].